热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE anti-mouse CD115 (CSF-1R) Antibody
产品名称：
PE anti-mouse CD115 (CSF-1R) Antibody
产品类别：
抗体
产品编号：
135505
产品应用：
135505
[价格]
规格 价格 库存
50µg ￥ 1404 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of ligand binding1. The LEAF? purified antibody (Endotoxin <0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays.

It has been reported that CD115 can be rapidly internalized, especially when samples are exposed to room temperature. Approximate 33% decrease in CD115 expression has been observed between 0 and 4 hours after sample collection, while overnight incubation of the cells results in complete CD115 downregulation.?Pre-treatment with EDTA and low temperatures (2 to 8°C) helps in maintaining surface expression of CD1154.

Application References

(PubMed link indicates BioLegend citation)
  1. Sudo T, et al. 1995. Oncogene 11:2469.
  2. Murayama T, et al. 1999. Circulation 99:1740.
  3. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. PubMed
  4. Breslin WL, et al. 2013. J Immunol Methods. 390(1-2):1 PubMed
  5. Dong L, et al. 2016. Nature. 539:304–308. PubMed
Product Citations
  1. Liang Y, et al. 2021. Cell Death Differ. 28:2728. PubMed
  2. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  3. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  4. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  5. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  6. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
  7. Groenen AG, et al. 2022. J Lipid Res. 63:100167. PubMed
  8. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  9. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  10. Oliveira-Lima OC, et al. 2015. Immunobiology. . PubMed
  11. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  12. Takacs E, et al. 2017. J Immunol. 198:239. PubMed
  13. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  14. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  15. Lee MH, et al. 2018. J Immunol Res. 2018:1601079. PubMed
  16. Bratti M, et al. 2022. Front Immunol. 13:1029759. PubMed
  17. Hreha TN, et al. 2020. Front Immunol. 1.597916667. PubMed
  18. Sakai M, et al. 2020. Immunity. 51(4):655-670. PubMed
  19. Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed
  20. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  21. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
  22. Yang F, et al. 2020. Cancer Res. 80:3677. PubMed
  23. Fuster JJ, et al. 2020. Cell Rep. 33:108326. PubMed
  24. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  25. Voisin M, et al. 2021. Commun Biol. 4:420. PubMed
  26. Eisele AS, et al. 2022. Elife. 11:. PubMed
  27. Smith C, et al. 2012. Cancer Discovery. 2:722. PubMed
  28. Distel E, et al. 2014. Circ Res . 115:759. PubMed
  29. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  30. Barman PK, et al. 2019. J Immunol. 202:2720. PubMed
  31. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  32. Anderson SR, et al. 2019. Cell Rep. 27:2002. PubMed
  33. La Rose AM, et al. 2021. Mol Metab. 53:101265. PubMed
  34. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  35. Aktories P, et al. 2022. Cell Rep Methods. 2:100260. PubMed
  36. Tripathi H, et al. 2020. Stem Cell Rev Rep. 0.953472222. PubMed
  37. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  38. Li W, et al. 2021. PLoS Pathog. 17:e1009462. PubMed
  39. Gadd V, et al. 2016. PLoS One. 11: 0157771. PubMed
  40. Bouchareychas L, et al. 2020. Cell Reports. 32(2):107881. PubMed
  41. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  42. Johansson J, et al. 2013. J Neurosci. 33:16016. PubMed
  43. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  44. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
  45. Clemente C, et al. 2018. Nat Commun. 9:910. PubMed
  46. Evrard M et al. 2018. Immunity. 48(2):364-379 . PubMed
  47. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  48. Ulrich V, et al. 2016. EMBO Mol Med. 8: 643 - 653. PubMed
  49. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  50. Chen S, et al. 2014. Biochem Biophys Res Commun. 446:1002. PubMed
  51. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  52. Foster G, et al. 2015. J Immunol. 195: 5380 - 5392. PubMed
  53. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  54. Ryu J, et al. 2013. Circulation. 127:710. PubMed
  55. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  56. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  57. Hussein M, et al. 2015. PLoS One. 10: 0135218. PubMed
  58. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  59. Petriello MC, et al. 2018. Toxicol Sci. 162:548. PubMed
  60. Steinmetz O, et al. 2016. J Infect Dis. 10.1093/infdis/jiv763. PubMed
  61. Yá?ez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  62. Di Liberto G et al. 2018. Cell. 175(2):458-471 . PubMed
RRID
AB_1937254 (BioLegend Cat. No. 135505) AB_1937253 (BioLegend Cat. No. 135506)

Antigen Details

Structure
Ig superfamily, 145 kD
Distribution

Monocytes/macrophages, peritoneal exudate cells, plasmacytoid and conventional dendritic cells, osteoclasts

Function
Growth factor receptor, tyrosine kinase
Ligand/Receptor
Macrophage colony stimulating factor (M-CSF), IL-34
Cell Type
Dendritic cells, Macrophages, Monocytes, Osteoclasts
Biology Area
Immunology
Molecular Family
CD Molecules, Cytokine/Chemokine Receptors
Antigen References
  1. Sudo T, et al. 1995 Oncogene 11:2469.
  2. Murayama T, et al. 1999 Circulation 99:1740.
  3. Goswami S, et al. 2005 Cancer Res. 65:5278.
  4. Yu W, et al. 2008 J. Leuko. Biol. 84:852.
Gene ID
12978 View all products for this Gene ID
UniProt
View information about CD115 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线